Park Hwayong, Hwang Youn-Hwan, Yang Hye Jin, Kim Hyun-Kyu, Song Kyung Seuk, Ma Jin Yeul
KM-based Herbal Drug Development Group, Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, Daejeon 305-811, Republic of Korea.
Nutraceutical Food R&D center, Kolmar BNH, 22-15 Sandan-gil, Jeonui-myeon, Sejong 339-851, Republic of Korea.
J Ethnopharmacol. 2014 Oct 28;156:182-9. doi: 10.1016/j.jep.2014.09.004. Epub 2014 Sep 16.
Guibi-tang (Guipi-tang in Chinese and Kihi-to in Japanese) is a multi-herb traditional medicine commonly prescribed to treat psychoneurosis in East Asia. Although this medicine has been widely used, there is little available information on the safety and toxicity of Guibi-tang, especially on the fermented one.
Guibi-tang, composed of 12 herbs, was fermented with bacteria and lyophilized. Single dose acute toxicity in rats was observed for 14 days after administration. Genetic toxicity of fermented Guibi-tang was evaluated on bacterial reverse mutation in Salmonella and Escherichia spp., chromosome aberrations in Chinese hamster ovary cells, and micronucleus formation in mice. Ingredients in FGBT were identified and quantified by high performance liquid chromatography-mass spectrometry.
In acute oral toxicity study, behavior, clinical signs and body weight changes were normal observing in all experimental animals. No revertant colonies were found in any bacterial cultures examined. Morphological or numerical anomalies and significant increased number of aberrant metaphases were not observed. Micronucleus assay showed no significant increases in the frequency of inducing micronuclei in any dose examined. Decursinol, decursin, glycyrrhizin, and 6-gingerol in fermented Guibi-tang were identified and quantitated. As a whole, no acute and genotoxic effects were found in all the assays and parameters analyzed.
Fermented Guibi-tang was recognized as safe and non-toxic, and therefore can be used for applications of traditional medicine in modern complementary and alternative therapeutics and health care.
归脾汤(中文为归脾汤,日文为きひと)是一种多草药传统药物,在东亚地区常用于治疗神经官能症。尽管这种药物已被广泛使用,但关于归脾汤安全性和毒性的信息却很少,尤其是发酵后的归脾汤。
由12味草药组成的归脾汤经细菌发酵后冻干。给药后观察大鼠单剂量急性毒性14天。通过沙门氏菌和大肠杆菌的细菌回复突变试验、中国仓鼠卵巢细胞的染色体畸变试验以及小鼠的微核形成试验来评估发酵归脾汤的遗传毒性。采用高效液相色谱 - 质谱联用技术对发酵归脾汤中的成分进行鉴定和定量。
在急性经口毒性研究中,所有实验动物的行为、临床症状和体重变化均正常。在所检测的任何细菌培养物中均未发现回复菌落。未观察到形态学或数值异常以及异常中期相数量的显著增加。微核试验表明,在所检测的任何剂量下,诱导微核的频率均未显著增加。鉴定并定量了发酵归脾汤中的当归醇、当归素、甘草酸和6 - 姜酚。总体而言,在所有分析的试验和参数中均未发现急性和遗传毒性作用。
发酵归脾汤被认为是安全无毒的,因此可用于现代补充和替代疗法及医疗保健中的传统医学应用。